Interpreting TRIPS: Globalisation of Intellectual Property Rights and Access to Medicines - Image 1

£95.00

Bloomsbury Interpreting TRIPS: Globalisation of Intellectual Property Rights and Access to Medicines

Name: Interpreting TRIPS: Globalisation of Intellectual Property Rights and Access to Medicines
Brand: Bloomsbury
Price: 95.0 GBP
Availability: InStock

International

It has never been this cheap. We have no record of a lower price.

£95 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 584 days • 584 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 584 days • 7 price levels

Days at Price

Current Price

Price Analysis

Most common price: £95 (283 days, 48.5%)

Price range: £95 - £169

Price levels: 7 different prices over 584 days

Description

Protection of intellectual property rights (IPRs) has become a global issue. The Trade-Related Aspects of Intellectual Property (TRIPS) Agreement outlines the minimum standards for IPR protection for WTO members and offers a global regime for IPR protection. However, the benefits of TRIPS are more questionable in poorer countries where national infrastructure for research and development (R&D) and social protection are inadequate, whereas the cost of innovation is high. Today, after more than a decade of intense debate over global IPR protection, the problems remain acute, although there is also evidence of progress and cooperation. This book examines various views of the role of IPRs as incentives for innovation against the backdrop of development and the transfer of technology between globalised, knowledge-based, high technology economies. The book retraces the origins, content and interpretations of the TRIPS Agreement, including its interpretations by WTO dispute settlement organs. It also analyses sources of controversy over IPRs, examining pharmaceutical industry strategies of emerging countries with different IPR policies. The continuing international debate over IPRs is examined in depth, as are TRIPS rules and the controversy about implementing the 'flexibilities' of the Agreement in the light of national policy objectives. The author concludes that for governments in developing countries, as well as for their business and scientific communities, a great deal depends on domestic policy objectives and their implementation. IPR protection should be supporting domestic policies for innovation and investment. This, in turn requires a re-casting of the debate about TRIPS, to place cooperation in global and efficient R&D at the heart of concerns over IPR protection.

Product Specifications

Brand: Bloomsbury
Format: hardcover
ASIN: 184113953X
Category: Books > Subjects > Business, Finance & Law > Law > International
Domain: Amazon UK
Release Date: 21 March 2011
Listed Since: 31 December 2009

Barcode

No barcode data available

Bloomsbury Interpreting TRIPS: Globalisation of Intellectual Property Rights and Access to Medicines

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

The International Political Economy of Intellectual Property Rights (New Horizons in Intellectual Property series)

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Pharmaceutical Patent Protection and World Trade Law: The Unresolved Problem of Access to Medicines (Routledge Research in Intellectual Property)

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Trade Related Aspects of Intellectual Property Rights: A Commentary on the TRIPS Agreement (Oxford Commentaries on International Law)

INTELLECTUAL PROPERTY RIGHTS:LEGAL & ECONOMIC CHALLENGES FOR DEVEL IPDS CLOTH: Legal and Economic Challenges for Development (Initiative for Policy Dialogue)

Patent Rights in Pharmaceuticals in Developing Countries: Major Challenges for the Future

Intellectual Property and Access to Medicines in Africa: A Regional Framework for Access (Routledge Research in Intellectual Property)

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Oxford University Press - Balancing Wealth and Health Book

Springer - Intellectual Property and Health Technologies

Patent Protection for Second Medical Uses (Aippi Law)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

EU Competition Law and Intellectual Property Rights (Elgar Competition Law and Practice series)

Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health? (Palgrave Studies in Public Health Policy Research)

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Patentwesen und Innovation: Eine wirtschaftliche Analyse der Zusammenhänge am Beispiel der pharmazeutischen Branche

Routledge Intellectual Property and Access to Medicines in Africa

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

A Biotech Manager's Handbook: A Practical Guide (Woodhead Publishing Series in Biomedicine)

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)